Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Trollfors

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|March 18, 2000
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussisJ Taranger, B Trollfors, T Lagergård, et al.
Pediatric Infectious Disease|November 1, 1984
Incidence and prognosis of acute epiglottitis in children in a Swedish regionB Claesson, B Trollfors, B Ekström-Jodal, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1988
Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assayG Zackrisson, I Krantz, T Lagergård, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussisB Trollfors, J Taranger, T Lagergård, et al.
The Pediatric Infectious Disease Journal|February 1, 1996
Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccineB A Claesson, B Trollfors, P W Anderson, et al.
Vaccine|August 3, 2001
Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccineN Knutsson, B Trollfors, J Taranger, et al.
The Journal of Pediatrics|April 1, 1997
Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussisB Trollfors, J Taranger, T Lagergård, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1987
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effectsS Rödjer, K Alestig, J Bergmark, et al.
The Pediatric Infectious Disease Journal|August 1, 1991
Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of ageB A Claesson, R Schneerson, T Lagergård, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsJ Taranger, B Trollfors, T Lagergård, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|March 18, 2000
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussisJ Taranger, B Trollfors, T Lagergård, et al.
Pediatric Infectious Disease|November 1, 1984
Incidence and prognosis of acute epiglottitis in children in a Swedish regionB Claesson, B Trollfors, B Ekström-Jodal, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1988
Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assayG Zackrisson, I Krantz, T Lagergård, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussisB Trollfors, J Taranger, T Lagergård, et al.
The Pediatric Infectious Disease Journal|February 1, 1996
Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccineB A Claesson, B Trollfors, P W Anderson, et al.
Vaccine|August 3, 2001
Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccineN Knutsson, B Trollfors, J Taranger, et al.
The Journal of Pediatrics|April 1, 1997
Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussisB Trollfors, J Taranger, T Lagergård, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1987
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effectsS Rödjer, K Alestig, J Bergmark, et al.
The Pediatric Infectious Disease Journal|August 1, 1991
Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of ageB A Claesson, R Schneerson, T Lagergård, et al.
The Pediatric Infectious Disease Journal|February 1, 1997
Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infantsJ Taranger, B Trollfors, T Lagergård, et al.
Pageof 18